Skip to main content
. 2018 Sep 12;16:255. doi: 10.1186/s12967-018-1629-x

Fig. 1.

Fig. 1

Changes (baseline and one-month follow-up) in biomarker levels in different patient subgroups (HBOT group and disease control) were compared using the paired-t test. a KDR+/CD34+ (%), b CD133+/CD34+ (%), c TBARS, d thiol, e hs-CRP